Elimination of leukemia in the absence of lethal graft versus host disease after allogeneic bone marrow transplantation.

被引：0
|
作者：
Drobyski, WR
Gendelman, M
Vodanovic-Jankovic, S
Gorski, J
机构：
[1] Med Coll Wisconsin, Bone Marrow Transplant Program, Milwaukee, WI 53226 USA
[2] Blood Res Inst, Milwaukee, WI USA
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3236
引用
收藏
页码：819A / 819A
页数：1
相关论文
共 50 条
  • [21] Graft versus host disease and gastrointestinal symptoms of pediatric patients after allogeneic bone marrow transplantation
    Bujanover, Y
    Bielorai, B
    Toren, A
    Weiss, B
    GASTROENTEROLOGY, 2004, 126 (04) : A511 - A511
  • [22] Incidence and risks for sclerodermatous chronic graft-versus-host disease after allogeneic marrow or blood transplantation.
    Pavletic, SZ
    Lynch, JC
    Sannoufi, S
    Ketcham, MA
    Bishop, MR
    Tarantolo, S
    Bociek, RG
    Kessinger, MA
    BLOOD, 2000, 96 (11) : 194A - 195A
  • [23] Phimosis as a manifestation of chronic graft-versus-host disease after allogeneic bone marrow transplantation
    M Kami
    Y Kanda
    M Sasaki
    N Takeda
    Y Tanaka
    T Saito
    S Ogawa
    H Honda
    S Chiba
    K Mitani
    H Hirai
    Y Yazaki
    Bone Marrow Transplantation, 1998, 21 : 721 - 723
  • [24] Eosinophilic cationic protein (ECP) as a marker of graft versus host disease (GVHD) in pediatric allogeneic bone marrow transplantation.
    Cole, CH
    Loh, R
    BLOOD, 1997, 90 (10) : 4398 - 4398
  • [25] MANIPULATION OF GRAFT-VERSUS-HOST DISEASE FOR A GRAFT-VERSUS-LEUKEMIA EFFECT AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION IN AKR MICE WITH SPONTANEOUS LEUKEMIA LYMPHOMA
    TRUITT, RL
    SHIH, CCY
    LEFEVER, AV
    TRANSPLANTATION, 1986, 41 (03) : 301 - 310
  • [26] GRAFT VERSUS HOST-REACTION AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
    GLUCKMAN, E
    DEVERGIE, A
    BLASETTI, A
    SOHIER, J
    GISSELBRECHT, C
    BOIRON, M
    BERNARD, J
    NOUVELLE REVUE FRANCAISE D HEMATOLOGIE, 1980, 22 : R48 - R49
  • [27] Risk factors for acute graft versus host disease following allogeneic non-myeloablative bone marrow transplantation.
    George, RT
    Sykes, M
    Spitzer, TR
    JOURNAL OF INVESTIGATIVE MEDICINE, 2003, 51 : S374 - S375
  • [28] GRAFT VERSUS HOST-DISEASE FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION
    CHAO, NJ
    CURRENT OPINION IN IMMUNOLOGY, 1992, 4 (05) : 571 - 576
  • [29] SIGNIFICANCE OF GRAFT-VERSUS-HOST DISEASE IN ALLOGENEIC BONE-MARROW TRANSPLANTATION
    NAKAMURA, H
    TESHIMA, H
    HIRAOKA, A
    SHIBATA, H
    INOUE, T
    MASAOKA, T
    ACTA HAEMATOLOGICA JAPONICA, 1987, 50 (08): : 1627 - 1633
  • [30] GRAFT-VERSUS-HOST DISEASE FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION
    YOSHIKAWA, S
    AKAO, Y
    HIRAIWA, A
    SAO, H
    YAMAUCHI, T
    TAHARA, T
    YOSHIKAWA, H
    MATSUYAMA, K
    KIMURA, S
    KITAYAMA, S
    TANABE, S
    UNO, H
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1984, 14 : 509 - 518
12345